Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. CRISIL's Marketable Securities for the quarter that ended in Jun. 2026 was ₹9,554 Mil.
CRISIL's annual Marketable Securities
increased
from Dec. 2023 (₹7,860 Mil) to Dec. 2024 (₹10,723 Mil) but then
declined
from Dec. 2024 (₹10,723 Mil) to Dec. 2025 (₹10,325 Mil).
Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".
CRISIL Marketable Securities Related Terms
CRISIL Marketable Securities Historical Data
* Premium members only.
The historical data trend for CRISIL's Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Marketable Securities of ₹9,554 Mil mean?
CRISIL (BOM:500092) has a Marketable Securities of ₹9,554 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on CRISIL and its competitors.
Is CRISIL's Marketable Securities too high?
CRISIL's current Marketable Securities is ₹9,554 Mil. Overall, CRISIL has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does CRISIL's Marketable Securities compare to SPGI and CME?
CRISIL's Marketable Securities of ₹9,554 Mil can be compared against companies in the Capital Markets industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Capital Markets company?
A good Marketable Securities depends on the Capital Markets industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on CRISIL and its competitors. CRISIL's current Marketable Securities is ₹9,554 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CRISIL stock overvalued right now?
Based on GuruFocus' analysis, CRISIL (BOM:500092) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹5,824.89, compared to a current price of ₹4,513.15 — trading 22.5% below its estimated fair value. The current Marketable Securities is ₹9,554 Mil. CRISIL's overall GF Score™ is 96/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For CRISIL (BOM:500092), the current Marketable Securities is ₹9,554 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CRISIL (BOM:500092) Overvalued in 2026?
Based on GuruFocus' analysis, CRISIL stock appears to be undervalued.
The current stock price of ₹4,513.15 is trading 22.5% below its estimated GF Value™ of ₹5,824.89.
GuruFocus considers CRISIL to be Modestly Undervalued.
Key valuation signals for BOM:500092:
Marketable Securities: ₹9,554 Mil
GF Value™: ₹5,824.89 vs. price of ₹4,513.15 (22.5% below fair value)
No single metric tells the full story. See the BOM:500092 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CRISIL Ltd provides research and analytics solutions for clients of all sizes. It operates through segments of Ratings services, and Research, Analytics & Solutions. The Ratings services segment includes credit ratings for corporates, banks, bank loans, credit analysis services, grading services and analytical services. The Research, Analytics and solutions segment which generates key revenue, includes research and risk solutions, industry reports, customized research assignments, subscription to data services, independent equity research (IER), IPO gradings, training, credit ratings for small and medium enterprises, advisory services and a comprehensive range of risk management tools, analytics and solutions to financial institutions, banks and corporates in India.
96GF Score
Get the complete analysis for BOM:500092
Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:500092 has been successfully added to your 
